Ebselen.

Ebselen works as a glutathione peroxidase mimic and consumes reduced glutathione as the electron donor in each catalytic turn. Without glutathione the selenium centre cannot cycle, so glutathione status sets its activity.

N-acetylcysteine supplies cysteine, the rate-setting amino acid for glutathione synthesis. Since ebselen burns through reduced glutathione as it cycles, keeping cysteine supply up sustains the reducing partner it needs.

Cysteine is the limiting building block of glutathione, the reductant ebselen depends on. It can also reduce the selenium centre directly through its own thiol.

Dihydrolipoate is a dithiol that reduces oxidised selenium centres and also regenerates glutathione. Both routes return ebselen to its active state without draining the glutathione pool as fast.

Ebselen imitates the selenocysteine active site of glutathione peroxidase, while dietary selenium supplies the real enzyme. The two cover the same peroxide-removing step through a synthetic and a native route.

Tocopherol stops the propagation of lipid radical chains, and ebselen reduces the hydroperoxides that are left behind. Acting at different points of the same lipid peroxidation sequence, they do not duplicate each other.

Ascorbate regenerates oxidised tocopherol and helps keep tissue thiols reduced, which indirectly supports the glutathione supply ebselen consumes. The two operate in different phases, water and membrane.

Superoxide dismutase turns superoxide into hydrogen peroxide, which then needs removing. Ebselen performs that second step, so pairing them avoids an accumulation between the two stages.

Catalase clears hydrogen peroxide at high concentrations while a glutathione peroxidase mimic handles the lower range and organic hydroperoxides too. Their concentration ranges and substrate scope differ, so they cover each other.

Ebselen works like a glutathione peroxidase mimic, handing electrons from a thiol to a peroxide and leaving oxidised glutathione behind. Glutathione reductase puts that glutathione back into its reduced form, and it can only do so with FAD, which the body builds from riboflavin. Low riboflavin status therefore constrains the same recycling loop ebselen depends on. This is cofactor biochemistry rather than a tested combination.

Ebselen's peroxidase-like activity is thiol-dependent, so the size of the reduced glutathione pool sets how fast it can turn over. Methionine feeds that pool through the transsulfuration pathway, which converts homocysteine to cystathionine and then to cysteine. The relationship is a supply chain into the cofactor, not a demonstrated clinical effect.

Ubiquinol works inside the lipid bilayer, where it intercepts propagating lipid radicals. Ebselen reduces the hydroperoxides that those reactions leave behind, including phospholipid hydroperoxides, without needing them cleaved from the membrane first. The two act at different steps of the same peroxidation sequence. No combination trial in people supports this pairing.

Astaxanthin spans the membrane and quenches singlet oxygen and lipid radicals. Ebselen consumes the hydroperoxide products of that chemistry using thiol reducing power. The pairing is a plausible division of labour on paper and has not been measured together in humans.

Ebselen reacts with protein cysteine residues to form a selenenyl sulfide. Where those cysteines are holding a zinc ion, the reaction can release the metal, which is how ebselen has been used experimentally to mobilise zinc from metallothionein. The direction of the interaction depends on zinc status and is a laboratory observation, not a dosing recommendation.

Free copper cycles between two oxidation states and can generate hydroxyl radicals from hydrogen peroxide. Ebselen removes hydrogen peroxide using thiol equivalents, which lowers the substrate available for that reaction. Copper also binds thiols directly, so the two compete for the same reduced pool. Read this as mechanistic chemistry, not a tested pairing.

Ebselen reduces hydrogen peroxide and lipid hydroperoxides, the two substrates iron uses to initiate and propagate radical chains. Whether that matters depends on how much loosely bound iron is present, which is normally very little because transferrin and ferritin keep it sequestered. The interaction is chemical and has not been quantified in people taking both.

Taurine reacts with hypochlorous acid produced by myeloperoxidase to form the more stable taurine chloramine. Ebselen acts on hydroperoxides and peroxynitrite instead. The chemistries do not overlap, so the pairing is complementary in principle. No human data supports combining them.

Quercetin donates hydrogen atoms to radicals and chelates transition metals. Ebselen instead catalyses the reduction of peroxides using glutathione. Both raise the same laboratory markers of lower oxidative load, which is a marker and not a clinical outcome.